Repeated exposure to sufficiently high doses of Δ9-tetrahydrocannabinol (THC) for an extended period (months to years) can result in adverse acute and long-term mental, physical https://caricuan88.site/50-best-sober-living-in-texas-with-pricing/ and social consequences. Learning mechanisms (such as cue reactivity and operant learning) further explain long-lasting behavioural changes. Other factors that increase risk of SUDs are parental use of drugs, permissive attitudes towards drug use, mental disorders, poor relationships and unfavourable child-rearing161,162.
Differential Diagnosis in Cannabis Use Disorder
It also discusses the biological and social mechanisms underlying the development of CUD and considers the potential impacts of global trends to allow legal access to cannabis use. The Primer concludes with the major outstanding research questions in the field, and considers how researchers may advance these areas. Cannabidiol (CBD) products that contain no or very small amounts of THC are not reviewed.
Drug Classifications Chart
Effective treatment focuses on managing withdrawal symptoms, reducing cannabis dependence, and addressing co-occurring psychiatric disorders or substance-induced mental disorders. CUD cannabis use disorder is a significant public health concern, with implications for mental health, physical health, and social functioning. The condition can lead to various adverse outcomes, including impaired cognitive abilities, reduced motivation, respiratory issues, and increased risk of psychiatric disorders.
Zung Self-Rating Anxiety Scale
- For these analyses, we examined the subtypes that would arise if only 1 out of 11 criteria (to mimic the diagnostic threshold for abuse) or 3 out of 11 criteria (to mimic the threshold for dependence) were required.
- Little is known about interactions between the effects of cannabis and other drugs55.
Using visual inspection to compare item response theory total information curves for the DSM-5 substance use disorder criteria with and without craving produced inconsistent results (42, 47, 88). Using statistical tests to compare total information curves, the drug addiction addition of craving to the dependence criteria did not significantly add information (45, 57). However, when craving and the three abuse criteria were added, total information was increased significantly for nicotine, alcohol, cannabis, and heroin, although not for cocaine use disorders (45, 57). Clinicians expressed enthusiasm about adding craving at work group presentations and on the DSM-5 web site. In the end, while the psychometric benefit in adding a craving criterion was equivocal, the view that craving may become a biological treatment target (a nonpsychometric perspective) prevailed. While awaiting the development of biological craving indicators, clinicians and researchers can assess craving with questions like those used in the item response theory studies (42, 45, 47, 49, 57, 88).
- Adverse pharmacodynamic (between drugs with similar effects) and pharmacokinetic (between drugs that alter metabolic enzymes) interactions can complicate clinical presentation.
- For both current and lifetime dependence, the diagnostic criteria met by the highest proportion of individuals were inability to cut down, use despite physical/psychological problems, and large amounts of time spent in substance-related activities (Table 3).
- Twin studies that have estimated the effects of shared and unshared environmental factors on cannabis use provide more consistent evidence of unique genetic liability.
- Since then, knowledge about psychiatric disorders, including substance use disorders, has advanced greatly.